Gender Solutions® Patello-Femoral Joint System

The Gender Solutions PFJ System is designed to address the anatomical differences among men and women with a reproducible instrumentation platform, aiming to simplify patello-femoral arthroplasty (PFA).

Compared to total knee arthroplasty:

  • PFA is associated with shorter postoperative rehabilitation1
  • PFA is associated with better knee kinematics in the sagittal plane because of the preservation of the tibiofemoral articulation, menisci, ACL and other supporting ligaments1
  • PFA patients showed better functionality, less blood loss and greater return to activity2

The Gender Solutions PFJ System features:

  • Increased Trochlear Groove Angle*
  • Modified, Thinner Anterior Flange*
  • Proprietary Guided Milling System

The PFJ Prosthesis is compatible with Gender Solutions Natural-Knee® Flex, and NexGen® Standard All-Polyethylene, Porous, or Augmentation Patellae. 

 

Previous page

References

*Features only included in sizes 1-4 of the Gender Solutions PFJ system and are in comparison to the standard NexGen femoral components

  1. Morris, M.J. et al. Clinical Results of Patellofemoral Arthroplasty. The Journal of Arthroplasty. 28(9): 199-201, 2013.
  2. Dahm, D.L. et al. Patellofemoral Arthroplasty Versus Total Knee Arthroplasty in Patients with Isolated Patellofemoral Osteoarthritis. The American Journal of Orthopedics. 39(10): 487-491, 2010.

 

Legal Manufacturer:

Zimmer, Inc.
1800 West Center Street
Warsaw, Indiana 46580 USA

All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  
This material is intended for health care professionals. Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert and information on this website. To obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please call 1-800-348-2759, press 4 for 411 Technical Support.